Morgan Stanley
TYRA icon

Morgan Stanley’s Tyra Biosciences TYRA Stock Holding History

Morgan Stanley’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.59M Buy
300,322
+179,837
+149% +$5.95M ﹤0.01% 3714
2026
Q1 		$4.61M Buy
120,485
+1,587
+1% +$51.4K ﹤0.01% 4197
2025
Q4 		$3.13M Sell
118,898
-203,245
-63% -$3.73M ﹤0.01% 4510
2025
Q3 		$4.51M Sell
322,143
-56,259
-15% -$641K ﹤0.01% 4243
2025
Q2 		$3.62M Buy
378,402
+197,812
+110% +$1.88M ﹤0.01% 4320
2025
Q1 		$1.68M Buy
180,590
+106,441
+144% +$1.38M ﹤0.01% 4715
2024
Q4 		$1.03M Buy
74,149
+5,233
+8% +$95K ﹤0.01% 5075
2024
Q3 		$1.62M Buy
68,916
+4,385
+7% +$92.1K ﹤0.01% 4769
2024
Q2 		$1.03M Buy
64,531
+29,294
+83% +$504K ﹤0.01% 4943
2024
Q1 		$578K Sell
35,237
-431
-1% -$7.07K ﹤0.01% 5243
2023
Q4 		$494K Buy
35,668
+17,384
+95% +$225K ﹤0.01% 5300
2023
Q3 		$252K Sell
18,284
-486
-3% -$7.21K ﹤0.01% 5476
2023
Q2 		$320K Buy
18,770
+3,461
+23% +$50.2K ﹤0.01% 5438
2023
Q1 		$246K Buy
15,309
+4,906
+47% +$58.4K ﹤0.01% 5612
2022
Q4 		$79.1K Sell
10,403
-2,119
-17% -$15K ﹤0.01% 6085
2022
Q3 		$110K Sell
12,522
-914
-7% -$8.36K ﹤0.01% 6031
2022
Q2 		$96K Buy
13,436
+11,865
+755% +$94.5K ﹤0.01% 6297
2022
Q1 		$16K Sell
1,571
-34,177
-96% -$406K ﹤0.01% 7239
2021
Q4 		$503K Buy
+35,748
New +$710K ﹤0.01% 5538

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Morgan Stanley's TYRA Position: Q2 2026 in Review

Morgan Stanley increased its Tyra Biosciences (TYRA) stake by 149% in Q2 2026, buying an estimated $5.95M and bringing the position to 300,322 shares worth $9.59M. The position accounts for ﹤0.01% of the portfolio, ranked #3714.

Morgan Stanley first reported a position in TYRA in Q4 2021 and has held it in 19 quarters since. 168 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • Morgan Stanley held 300,322 shares of Tyra Biosciences worth $9.59M as of Q2 2026.
  • Morgan Stanley bought 179,837 Tyra Biosciences shares in Q2 2026, an estimated $5.95M.
  • Tyra Biosciences made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #3714 holding.
  • Morgan Stanley first reported a position in Tyra Biosciences in Q4 2021 and has held it in 19 quarters since.
  • 168 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.